- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05850650
The Effect of Post-extraction Collagen Sponge Application on Alveolar Osteitis
The Effect of Collagen Sponge Placed in the Socket After Surgical Extraction of Mandibular Third Molars on the Incidence of Alveolar Osteitis. A Randomized Controlled Trial
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Nedal A Abu-Mostafa, Assistant P
- Phone Number: 00966506275782
- Email: nabumostafa@gmail.com
Study Locations
-
-
-
Riyadh, Saudi Arabia, 11681
- Riyadh Colleges of Dentistry and Pharmacy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Forty patients aged between 18- 40 years old, ASA1, who have bilateral symmetrical impacted lower third molars and visit the oral surgery clinics of King Saud Medical City for extraction.
Exclusion Criteria:
Uncontrolled systemic diseases, diabetes, bone diseases, smokers, epinephrine contraindications, pregnant women, breastfeeding women, and those who were using oral contraceptives.
Other exclusion criteria are the presence of acute infection and facial swelling, cystic lesions, and TMJ problems. Moreover, any surgical extraction that lasts more than 30 minutes +/- 5 minutes, or has been done without the whole standardized steps will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Controlled
The extraction socket will not receive a collagen sponge
|
No collagen sponge application after surgical extraction of impacted 3rd molar
|
Experimental: Collagen
The extraction socket will receive a collagen sponge
|
Application of a collagen sponge after surgical extraction of impacted 3rd molar
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pre-extraction Pain score
Time Frame: Pre-extraction
|
Pain measurement by VAS (0-10).
0: no pain.
10: worst pain
|
Pre-extraction
|
Pre-extraction Halitosis
Time Frame: Pre-extraction
|
Halitosis in reported in the presence of a bad odor that is smelled by the investigator during the patient's speech
|
Pre-extraction
|
Pre-extraction Mouth opening
Time Frame: Pre-extraction
|
Maximum Mouth opening is taken by a caliber
|
Pre-extraction
|
Pain score Day3
Time Frame: 3 days after extraction
|
Pain measurement by VAS (0-10).
0: no pain.
10: worst pain
|
3 days after extraction
|
Pain score Day7
Time Frame: 7 days after extraction
|
Pain measurement by VAS (0-10).
0: no pain.
10: worst pain
|
7 days after extraction
|
Mouth opening Day7
Time Frame: 7 days after extraction
|
Maximum Mouth opening is taken by a caliber
|
7 days after extraction
|
Halitosis Day7
Time Frame: 7 days after extraction
|
Halitosis in reported in the presence of a bad odor that is smelled by the investigator during the patient's speech
|
7 days after extraction
|
Alveolar osteitis
Time Frame: After 3 days of extraction
|
is diagnosed if the patient complains of pain (more than 5) between day 2 and day 4 with empty sockets and food debris, with or without halitosis
|
After 3 days of extraction
|
Collaborators and Investigators
Investigators
- Principal Investigator: Nedal A Abu-Mostafa, Assistant P, nabumostafa@gmail.com
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alveolar Osteitis
-
Pierre Fabre MedicamentCompletedAlveolar OsteitisFrance, Lithuania, Latvia, Estonia
-
Medical University of ViennaRecruiting
-
T.C. ORDU ÜNİVERSİTESİCompletedAlveolar OsteitisTurkey
-
Contipro Pharma a.s.Completed
-
Universidad Complutense de MadridBio Nature Essences S.LCompletedAlveolar Osteitis
-
Ege UniversityCompletedAlveolar Osteitis | Impacted ToothTurkey
-
University of Dublin, Trinity CollegeRecruitingPain | Tooth Extraction | Alveolar Osteitis | Dry Socket | HealingIreland
-
Massachusetts General HospitalOral and Maxillofacial Surgery Foundation, Rosemont ,IllinoisCompleted
-
University of OsloCompletedPost-Operative Wound InfectionNorway
Clinical Trials on No collagen sponge application after surgical extraction of impacted 3rd molar
-
Dow University of Health SciencesEnrolling by invitation
-
University of BaghdadRecruitingImpacted Third Molar ToothIraq
-
Linyi People's HospitalCompletedImpacted Third Molar Tooth